PR Newswire - Ubie Announces Cumulative Total Funding of Over $125M as US Efforts Target Expansion into Generative AI and Provider Solutions

• Ubie's growth has been accelerated by recent strategic investment and acceptance into Mayo Clinic Platform Accelerate program
• Ubie's US Symptom Checker platform has seen 85% organic growth and a total user base of 4 million, helping deliver partnerships across patient advocacy and life sciences

NEW YORK, June 26, 2025 /PRNewswire/ -- Ubie, an AI-driven and medically vetted healthcare prediction platform that guides patients to the care they need, today announced that its cumulative funding since the company's founding in 2017 has reached over $125M. The funding includes a recent investment and support from leading companies worldwide, including Google, JAPAN POST CAPITAL Co., Ltd., NTT DOCOMO, INC., SEVEN-ELEVEN JAPAN CO., LTD., Japan Finance Corporation, and The Shoko Chukin Bank, Ltd.

Ubie previously announced Series C funding of $26.2M, with a cumulative total of $59.8M in August 2022. In the US, Ubie's highly accurate, medically-validated AI Symptom Checker has driven partnerships with key advocacy and life sciences companies. The number of users of Symptom Checker in the US recently reached over 4 million total users, with an 85% increase of monthly organic users since 2024.

"Ubie has seen an increasing understanding and acknowledgment of the capabilities and impact we provide to patients, providers, and the healthcare system," said Kota Kubo, Co-Founder and CEO of Ubie. "Our growth has been significant and multifaceted, supported by a growing user base, new customers, partnerships with key groups, and funding from established companies in healthcare. We continue to see increasing interest in our solution in the US, where we are currently focusing expansion efforts for patients, providers and pharmaceutical partners."

Generative AI and Provider Solutions

Ubie's approach of helping users navigate the burdensome, and sometimes difficult to understand, healthcare system has resonated with users and partners alike, resulting in the company accelerating the reach and impact of its Symptom Checker solution. Ubie is now working to implement generative AI in a way that will further enhance patient education, providing critical disease information and guidance toward appropriate care and treatments as early as possible in their journey.

Ubie is also developing a provider solution following its acceptance into the Mayo Clinic's Platform Accelerate program, which will allow Ubie to pressure test and fine tune the platform using the de-identified data of 3 million Mayo Clinic patients to refine the platform's accuracy.

Ubie Worldwide

Ubie's Symptom Checker is used by over 13 million people monthly worldwide, while in Japan Ubie offers the "Ubie Medical Navigator," a tool for medical institutions that provides solutions such as AI-powered patient intake and generative AI, has been adopted by over 1,800 medical institutions, and "Ubie for Pharma," which provides disease and treatment awareness information in collaboration with pharmaceutical companies.

These services support Ubie's aim of promoting the creation of a society where everyone can access appropriate medical care. The company is focused on creating significant synergies by combining the strengths of leading companies in Japan and overseas, including their advanced technological capabilities and nationwide networks, with Ubie's knowledge and technology in healthcare.

About Ubie

Founded in 2017, Ubie empowers individuals and healthcare professionals with the tools they need for better care. Leveraging cutting-edge disease prediction AI, Ubie guides 13+ million patients every month to seek appropriate medical attention through its free online Symptom Checker and equips 1,800+ provider organizations with clinical tools that streamline workflows and support better diagnoses and health outcomes. Trained on medical data, Ubie's marketing solutions power advanced targeting capabilities and high-performing digital campaigns for 21 out of top 30 world's top life science companies.

Learn more about our vision and work at https://ubiehealth.com/company or try our free Symptom Checker at https://ubiehealth.com/.